Unilabs returns to profit but weakened NHS demand continues

Continued weakening demand from the NHS along with capacity constraints in the first half hit sales at pathology and cancer diagnostics specialist Unilabs last year. The company, which trades as The Harley Street Breast Clinic and Unilabs, posted a 2.1% drop in turnover to £12m in the year ended 31 December 2018. However, cost of…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »